Table 2.

The comparison of gender, age, and course of disease of HBeAg negative CHB patients at baseline.

Group	Gender (n)		Age (year)	Course (year)
	Male	Female
A	18	12	38.15 ± 6.18*	8.56 ± 3.45
B	17	13	37.65 ± 7.09*	9.43 ± 4.38
C	16	14	46.35 ± 10.34	11.73 ± 4.43

*P < 0.05, compared to group C.